INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a worldwide burden and a major cause of death. The disease is accompanied by chronic inflammation and increased cellular turnover that is partly due to an overwhelming induction of apoptosis. In this study, we hypothesized that systemic markers of apoptosis are altered in patients with mild-to-severe COPD. MATERIALS AND METHODS: A total number of 64 patients and controls were enrolled in the study. Lung function parameters of all groups (nonsmoker, healthy smoker, COPD GOLD I&II, COPD GOLD III&IV) were evaluated at the time of inclusion. Enzyme-linked immunosorbent assays were used to quantify protein levels in serum samples. RESULTS: Serum contents of apoptotic end-products caspase-cleaved cytokeratin-18 and histone-associated-DNA-fragments were increased in patients with COPD, whereas anti-inflammatory soluble ST2 showed a peak in patients with COPD I&II (P=0.031) compared to healthy smokers. Levels of pro-inflammatory caspase-1/ ICE correlated significantly with the number of pack years (R=0.337; P=0.007). DISCUSSION: Our results indicate a systemic release of apoptosis-specific proteins as markers for increased cellular turnover accompanied by progression of COPD. Furthermore, soluble ST2 seems to have a critical role in the anti-inflammatory regulatory mechanism at early stages of the disease.
INTRODUCTION:Chronic obstructive pulmonary disease (COPD) is a worldwide burden and a major cause of death. The disease is accompanied by chronic inflammation and increased cellular turnover that is partly due to an overwhelming induction of apoptosis. In this study, we hypothesized that systemic markers of apoptosis are altered in patients with mild-to-severe COPD. MATERIALS AND METHODS: A total number of 64 patients and controls were enrolled in the study. Lung function parameters of all groups (nonsmoker, healthy smoker, COPD GOLD I&II, COPD GOLD III&IV) were evaluated at the time of inclusion. Enzyme-linked immunosorbent assays were used to quantify protein levels in serum samples. RESULTS: Serum contents of apoptotic end-products caspase-cleaved cytokeratin-18 and histone-associated-DNA-fragments were increased in patients with COPD, whereas anti-inflammatory soluble ST2 showed a peak in patients with COPD I&II (P=0.031) compared to healthy smokers. Levels of pro-inflammatory caspase-1/ ICE correlated significantly with the number of pack years (R=0.337; P=0.007). DISCUSSION: Our results indicate a systemic release of apoptosis-specific proteins as markers for increased cellular turnover accompanied by progression of COPD. Furthermore, soluble ST2 seems to have a critical role in the anti-inflammatory regulatory mechanism at early stages of the disease.
Authors: T Szerafin; T Niederpold; A Mangold; K Hoetzenecker; S Hacker; G Roth; M Lichtenauer; M Dworschak; E Wolner; H J Ankersmit Journal: Thorac Cardiovasc Surg Date: 2009-01-23 Impact factor: 1.827
Authors: N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins Journal: Nature Date: 1992-04-30 Impact factor: 49.962
Authors: Robert Newton; Neil S Holden; Matthew C Catley; Wale Oyelusi; Richard Leigh; David Proud; Peter J Barnes Journal: J Pharmacol Exp Ther Date: 2007-02-22 Impact factor: 4.030
Authors: Sandra Grumelli; David B Corry; Li-Zhen Song; Ling Song; Linda Green; Joseph Huh; Joan Hacken; Rafael Espada; Remzi Bag; Dorothy E Lewis; Farrah Kheradmand Journal: PLoS Med Date: 2004-10-19 Impact factor: 11.069
Authors: K Hoetzenecker; A Mitterbauer; E Guenova; T Schweiger; P Altmann; M Zimmermann; H Hofbauer; L Beer; W Klepetko; H J Ankersmit Journal: Wien Klin Wochenschr Date: 2013-03-27 Impact factor: 1.704
Authors: Tina E Faber; Annemieke Schuurhof; Annelies Vonk; Gerard H Koppelman; Marije P Hennus; Jan L L Kimpen; Riny Janssen; Louis J Bont Journal: PLoS One Date: 2012-05-04 Impact factor: 3.240